CB-4473

N/A

Report date: 2024/11/07 10:40:33
NME

Base Information

Drug NameCB-4473
Drug Alias NameCB-4473
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement C4-B inhibitors
TargetsComplement C4-B
Therapy Area/IndicationsImmune System DiseasesHematologic DiseasesKidney Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCatalyst Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCatalyst Biosciences Inc
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesHematologic DiseasesKidney Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A